Published in J Antimicrob Chemother on November 01, 1999
Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens. Antimicrob Agents Chemother (2004) 1.93
Pharmacodynamics of gemifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model of infection. Antimicrob Agents Chemother (2001) 0.98
Cultivation of Neisseria gonorrhoeae in liquid media and determination of its in vitro susceptibilities to quinolones. J Clin Microbiol (2005) 0.94
Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model. Antimicrob Agents Chemother (2004) 0.90
Pharmacodynamic modelling of in vitro activity of tetracycline against a representative, naturally occurring population of porcine Escherichia coli. Acta Vet Scand (2015) 0.87
An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis. Biomatter (2013) 0.87
Activity of gatifloxacin in an in vitro pharmacokinetic-pharmacodynamic model against Staphylococcus aureus strains either susceptible to ciprofloxacin or exhibiting various levels and mechanisms of ciprofloxacin resistance. Antimicrob Agents Chemother (2006) 0.86
Modeling the growth dynamics of multiple Escherichia coli strains in the pig intestine following intramuscular ampicillin treatment. BMC Microbiol (2016) 0.75
Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst (1995) 6.24
A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother (2001) 5.83
Cytogenetic Analysis of Chromosome 3 in DROSOPHILA MELANOGASTER: The Homoeotic Gene Complex in Polytene Chromosome Interval 84a-B. Genetics (1980) 5.39
Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol (2001) 4.18
Telemedicine versus face to face patient care: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2000) 4.16
In-vitro studies with ciprofloxacin, a new 4-quinolone compound. J Antimicrob Chemother (1984) 3.62
Sequence analysis of the L1 metallo-beta-lactamase from Xanthomonas maltophilia. Biochim Biophys Acta (1994) 3.52
Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med (1998) 3.45
Generic inhalers for asthma. BMJ (1994) 3.09
Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis. Infect Immun (1996) 3.09
Screening of urines with dipstrips: does it reduce workload and consumable costs? J Clin Pathol (1990) 2.68
EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect (2011) 2.65
Structure of a major immunogenic site on foot-and-mouth disease virus. Nature (1993) 2.55
The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol Assess (2000) 2.45
Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints. J Antimicrob Chemother (1998) 2.42
Extreme diversity, conservation, and convergence of spider silk fibroin sequences. Science (2001) 2.27
Epidemic infection by a gentamicin-resistant Staphylococcus aureus in three hospitals. Lancet (1976) 2.24
Conclusions of the corneal transplant follow up study. Collaborating Surgeons. Br J Ophthalmol (1997) 2.23
Importance of air quality and related factors in the prevention of infection in orthopaedic implant surgery. J Hosp Infect (1998) 2.17
MDM2 gene amplification in metastatic osteosarcoma. Cancer Res (1993) 2.15
Angular malalignment after intramedullary nailing of femoral shaft fractures. J Orthop Trauma (2001) 2.08
Sequence analysis and enzyme kinetics of the L2 serine beta-lactamase from Stenotrophomonas maltophilia. Antimicrob Agents Chemother (1997) 2.07
Lack of upward creep of glycopeptide MICs for methicillin-resistant Staphylococcus aureus (MRSA) isolated in the UK and Ireland 2001-07. J Antimicrob Chemother (2012) 2.04
Absolute and Unconditional Convergence in Normed Linear Spaces. Proc Natl Acad Sci U S A (1950) 2.02
Needlestick injuries among medical students. J Hosp Infect (1993) 1.96
Temperature-sensitive mutants of herpes simplex virus. Virology (1970) 1.83
Venous thromboembolism after acute stroke. Stroke (2001) 1.81
Clinical versus administrative data bases for CABG surgery. Does it matter? Med Care (1992) 1.70
Corneal graft survival and visual outcome. A multicenter Study. Corneal Transplant Follow-up Study Collaborators. Ophthalmology (1994) 1.69
The impaired driver: hospital and police detection of alcohol and other drugs of abuse in motor vehicle crashes. Ann Emerg Med (1994) 1.68
Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol (1999) 1.67
A complication of ilio-inguinal block for inguinal hernia repair. Anaesthesia (1988) 1.65
Detection of sodium channel toxins: directed cytotoxicity assays of purified ciguatoxins, brevetoxins, saxitoxins, and seafood extracts. J AOAC Int (1995) 1.63
Salt tolerance of EMRSA-16 and its effect on the sensitivity of screening cultures. J Hosp Infect (1997) 1.60
Estimating the prevalence of opioid dependence. Lancet (1985) 1.57
Vancomycin-resistant Staphylococcus aureus. Lancet (1998) 1.57
Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam. Br J Urol (1995) 1.56
Listeria monocytogenes and its role in human infection. J Infect (1988) 1.54
The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. Clin Microbiol Infect (2012) 1.53
Reducing stress responses in the pre-bypass phase of open heart surgery in infants and young children: a comparison of different fentanyl doses. Br J Anaesth (2000) 1.53
Contamination of wounds by direct inoculation in total hip arthroplasty: a prospective clinical study. J Hosp Infect (1998) 1.52
Simple method for production of internal control DNA for Mycobacterium tuberculosis polymerase chain reaction assays. J Clin Microbiol (1993) 1.52
Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections. BMJ (1994) 1.52
Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol (1995) 1.48
Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria. J Antimicrob Chemother (1997) 1.46
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing. Clin Microbiol Infect (2006) 1.45
Development of a novel assay method for colistin sulphomethate. Clin Microbiol Infect (2005) 1.44
Haemodynamic significance of incompetent calf perforating veins. Br J Surg (1991) 1.42
A simple approach to risk stratification in adult heart transplantation. Eur J Cardiothorac Surg (1999) 1.40
Azlocillin and mezlocillin: laboratory studies of their properties, including comparison with the antibacterial activity of other antibiotics. Arzneimittelforschung (1979) 1.39
Modification of piezoelectric vibratory gyroscope resonator parameters by feedback control. IEEE Trans Ultrason Ferroelectr Freq Control (1998) 1.39
Laparoscopic pericardial fenestration for malignant pericardial effusion. Lancet (1992) 1.39
Activity of moxifloxacin, administered once a day, against Streptococcus pneumoniae in an in vitro pharmacodynamic model of infection. Antimicrob Agents Chemother (1999) 1.39
Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol (1997) 1.39
A Condition For a Real Lattice to Define a Zeta Function. Proc Natl Acad Sci U S A (1951) 1.38
Outcome of heart-lung and bilateral sequential lung transplantation for cystic fibrosis: a UK national study. Eur Respir J (2005) 1.38
A clinical isolate of Aeromonas sobria with three chromosomally mediated inducible beta-lactamases: a cephalosporinase, a penicillinase and a third enzyme, displaying carbapenemase activity. J Antimicrob Chemother (1995) 1.38
Sequence analysis of two chromosomally mediated inducible beta-lactamases from Aeromonas sobria, strain 163a, one a class D penicillinase, the other an AmpC cephalosporinase. J Antimicrob Chemother (1995) 1.37
Spinal Pseudomonas chondro-osteomyelitis in heroin users. N Engl J Med (1972) 1.37
The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity. J Antimicrob Chemother (1984) 1.37
The Ohmeda 9000 syringe pump. The first of a new generation of syringe drivers. Anaesthesia (1990) 1.36
Interactions between aminoglycoside antibiotics and carbenicillin or ticarillin. Infection (1976) 1.35
Human metabolism of cefotaxime. J Antimicrob Chemother (1980) 1.34
Antimicrobial chemotherapy of human infection due to Listeria monocytogenes. Eur J Clin Microbiol Infect Dis (1995) 1.33
The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis. Tuber Lung Dis (1995) 1.33
Prophylactic oral fluconazole and candida fungaemia. Lancet (1991) 1.33
Influence of donor and histocompatibility factors on corneal graft outcome. Transplantation (1994) 1.31
Nucleotide and amino acid sequences of the metallo-beta-lactamase, ImiS, from Aeromonas veronii bv. sobria. Antimicrob Agents Chemother (1998) 1.29
Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus. J Antimicrob Chemother (1999) 1.28
Heterogeneous resistance to vancomycin in Staphylococcus aureus. J Antimicrob Chemother (2000) 1.28
A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus. Arch Intern Med (1995) 1.27
Delivering cervical cancer prevention services in low-resource settings. Int J Gynaecol Obstet (2005) 1.26
Short communication: Lassa fever in Sierra Leone: UN peacekeepers are at risk. Trop Med Int Health (2001) 1.26
Expression of lux genes in a clinical isolate of Streptococcus pneumoniae: using bioluminescence to monitor gemifloxacin activity. Antimicrob Agents Chemother (2002) 1.25
Outdoor allergens. Environ Health Perspect (2000) 1.25
Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire. J Antimicrob Chemother (2002) 1.24
Clothing in laminar-flow operating theatres. J Hosp Infect (1996) 1.23
Risk factors for and economic implications of prolonged ventilation after cardiac surgery. J Thorac Cardiovasc Surg (2005) 1.22
Distribution and expression of beta-lactamase genes among Aeromonas spp. J Antimicrob Chemother (1997) 1.22
A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection. J Antimicrob Chemother (1992) 1.21
Penetration of linezolid into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. J Antimicrob Chemother (2002) 1.21
Post-exposure prophylaxis for human immunodeficiency virus: knowledge and experience of junior doctors. Sex Transm Infect (2001) 1.21
Urinary symptoms and incontinence in women: relationships between occurrence, age, and perceived impact. Br J Gen Pract (1999) 1.20
A prospective, randomised trial of prophylactic antibiotics versus bag extraction in the prophylaxis of wound infection in laparoscopic cholecystectomy. Ann R Coll Surg Engl (2000) 1.20
Modification of bile acids by intestinal bacteria. Arch Intern Med (1972) 1.19
An eight-year survey of the antimicrobial susceptibility patterns of 85,971 bacteria isolated from patients in a district general hospital and the local community. J Antimicrob Chemother (1993) 1.19
Differential effects of oral, peripheral intravenous, and intraportal glucose on hepatic glucose uptake and insulin and glucagon extraction in conscious dogs. J Clin Invest (1983) 1.19
Streptococcus milleri and second trimester abortion. J Clin Pathol (1987) 1.17
Teicoplanin therapy for Staphylococcus aureus septicaemia: relationship between pre-dose serum concentrations and outcome. J Antimicrob Chemother (2000) 1.17
Regular exercise enhances insulin activation of IRS-1-associated PI3-kinase in human skeletal muscle. J Appl Physiol (1985) (2000) 1.16
Corneal transplantation in the United Kingdom and Republic of Ireland. Br J Ophthalmol (1993) 1.15
Malaria associated with pregnancy. Obstet Gynecol (1973) 1.15
Once-daily aminoglycoside dosing. Lancet (1993) 1.15